Sicys Bio Completes First Patient Procedure in U.S. Pivotal Trial for Next-Generation Bone Substitute
"Significant Progress Toward FDA Premarket Approval"
Sicys Bio announced on July 30 that it has successfully completed the first patient procedure in a pivotal clinical trial for 'Novosis Putty', its next-generation bone substitute, as part of the process for premarket approval (PMA) from the U.S. Food and Drug Administration (FDA).
Sicys Bio recently applied Novosis Putty during a transforaminal lumbar interbody fusion (TLIF) procedure for a patient with degenerative disc disease (DDD) at a spine specialty clinical institution in the United States. Patient enrollment is underway at around 30 spine specialty centers in both Korea and the United States, and the collected data is expected to serve as core clinical evidence for future regulatory approval applications.
Novosis Putty is a medical device featuring a sustained-release delivery platform, designed to gradually release bone morphogenetic protein (rhBMP-2) in alignment with the human bone healing process. The scaffold material itself serves as a bone graft substitute and is formulated as a putty that can be manually shaped as desired. It is designed to be stably positioned inside a cage, minimizing the risk of loss or migration of its components.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Hyunseung Yoo, CEO of Sicys Bio, stated, "We have successfully completed the first patient procedure with Novosis Putty in the United States, the world’s largest and most demanding medical device market. Following our exclusive North American commercialization partnership with DePuy Synthes, this achievement represents significant progress toward obtaining FDA premarket approval."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.